Share Price and Basic Stock Data
Last Updated: February 6, 2026, 3:44 pm
| PEG Ratio | -1.89 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vinyl Chemicals (I) Ltd operates within the chemical industry and has shown considerable revenue fluctuations over the years. For the fiscal year ending March 2023, the company reported sales of ₹1,013 Cr, a significant increase from ₹865 Cr in the previous fiscal year. However, the trailing twelve-month (TTM) revenue stood at ₹622 Cr, indicating a decline from the previous year’s performance. The quarterly sales data reveals a steady yet inconsistent trend; for instance, sales peaked at ₹270.66 Cr in December 2022, then fell to ₹106.93 Cr in March 2023 before recovering to ₹159.03 Cr by December 2023. This volatility reflects ongoing challenges in the market, including operational costs and competition. Despite these fluctuations, the company has managed to maintain a market capitalization of ₹391 Cr, which suggests a robust investor interest relative to its sales figures. The revenue from operations per share increased to ₹340.85 for the year ending March 2025, demonstrating the company’s ability to generate revenue effectively.
Profitability and Efficiency Metrics
Vinyl Chemicals reported an operating profit margin (OPM) of 2.19% for the fiscal year ending March 2025, which is relatively low compared to industry standards. The OPM has fluctuated over the years, with a peak of 5% recorded in March 2023, but it has since declined significantly, reflecting rising operational expenses. The company’s net profit for March 2025 was ₹22 Cr, with an earnings per share (EPS) of ₹12.17, down from ₹19.44 in the previous fiscal year. The return on equity (ROE) stood at 15.6%, indicating that the company is generating a reasonable return for its shareholders, though this is lower than the typical sector average. The interest coverage ratio (ICR) was exceptionally high at 763.53x, suggesting that the company is in a strong position to cover its interest obligations, particularly since it carries no borrowings. However, the cash conversion cycle (CCC) of 23 days indicates that while the company is efficient in managing its receivables and payables, there is room for improvement in inventory management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vinyl Chemicals reflects a strong financial position, with total borrowings reported at ₹0 Cr. The company’s reserves increased to ₹125 Cr in March 2025, showcasing a healthy accumulation of retained earnings and a commitment to growth. The current ratio stood at 1.93, indicating sufficient liquidity to meet short-term obligations, while the quick ratio of 1.46 further confirms the company’s financial stability. The price-to-book value (P/BV) ratio was 4.10x, which is relatively high, suggesting that the market values the company significantly above its book value, reflecting investor confidence in its future prospects. The return on capital employed (ROCE) of 21.1% indicates efficient use of capital to generate earnings, although it has seen a decline from previous years. The company’s asset turnover ratio of 2.20% shows that it is effectively utilizing its assets to generate revenue, although this is lower than the historical peak.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vinyl Chemicals (I) Ltd reveals a concentrated ownership structure, with promoters holding 50.41% of the shares, indicating a strong commitment from the founding members. Institutional investors appear to have a minimal presence, with foreign institutional investors (FIIs) holding 0.00% and domestic institutional investors (DIIs) at just 0.02%. This lack of institutional investment may reflect concerns about the company’s volatility and profitability metrics, which could deter larger investors. The public shareholding stood at 49.57%, with a total of 40,756 shareholders reported as of September 2025. The declining number of shareholders from 46,195 in September 2023 to 40,756 suggests a potential decrease in retail investor interest, which could impact liquidity and overall market sentiment regarding the stock. Despite these concerns, the steady promoter stake indicates a level of confidence in the company’s long-term strategy.
Outlook, Risks, and Final Insight
Looking ahead, Vinyl Chemicals faces both opportunities and risks. The company’s lack of debt positions it well to capitalize on growth opportunities without the burden of interest payments. However, the volatility in revenue and profit margins poses significant risks, especially in a competitive market where operational efficiencies are crucial. The decline in EPS and net profit reflects underlying challenges that need addressing, such as cost management and market positioning. Furthermore, the low institutional interest raises concerns about long-term investor confidence, which could impact share price stability. On a more positive note, if the company can stabilize its operational performance and improve profitability metrics, it may attract renewed investor interest. Overall, while the financial fundamentals suggest potential, the road ahead requires strategic focus on enhancing operational efficiency and market competitiveness to ensure sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 113 Cr. | 29.4 | 751/20.5 | 1.10 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 3,064 Cr. | 190 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 38.6 Cr. | 3.02 | 7.43/2.70 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,169.79 Cr | 210.36 | 313.36 | 219.29 | 0.26% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 270.66 | 106.93 | 115.31 | 154.40 | 159.03 | 168.27 | 155.63 | 150.34 | 146.40 | 172.88 | 151.23 | 151.89 | 169.48 |
| Expenses | 260.62 | 97.41 | 111.87 | 149.87 | 150.28 | 159.63 | 149.65 | 144.39 | 142.74 | 162.93 | 149.26 | 149.22 | 165.77 |
| Operating Profit | 10.04 | 9.52 | 3.44 | 4.53 | 8.75 | 8.64 | 5.98 | 5.95 | 3.66 | 9.95 | 1.97 | 2.67 | 3.71 |
| OPM % | 3.71% | 8.90% | 2.98% | 2.93% | 5.50% | 5.13% | 3.84% | 3.96% | 2.50% | 5.76% | 1.30% | 1.76% | 2.19% |
| Other Income | 0.16 | 0.99 | 1.26 | 0.82 | 0.64 | 1.73 | 0.78 | 1.05 | 2.99 | 0.19 | 4.09 | 1.27 | 2.48 |
| Interest | 0.17 | 0.94 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
| Depreciation | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 |
| Profit before tax | 10.01 | 9.54 | 4.66 | 5.31 | 9.36 | 10.33 | 6.73 | 6.95 | 6.61 | 10.11 | 6.02 | 3.88 | 6.15 |
| Tax % | 26.37% | 23.48% | 24.89% | 26.93% | 25.96% | 27.11% | 26.89% | 26.19% | 24.21% | 28.09% | 26.08% | 25.77% | 26.50% |
| Net Profit | 7.37 | 7.30 | 3.50 | 3.88 | 6.93 | 7.53 | 4.92 | 5.13 | 5.01 | 7.27 | 4.45 | 2.88 | 4.52 |
| EPS in Rs | 4.02 | 3.98 | 1.91 | 2.12 | 3.78 | 4.11 | 2.68 | 2.80 | 2.73 | 3.96 | 2.43 | 1.57 | 2.46 |
Last Updated: February 3, 2026, 3:46 pm
Below is a detailed analysis of the quarterly data for Vinyl Chemicals (I) Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 169.48 Cr.. The value appears strong and on an upward trend. It has increased from 151.89 Cr. (Sep 2025) to 169.48 Cr., marking an increase of 17.59 Cr..
- For Expenses, as of Dec 2025, the value is 165.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 149.22 Cr. (Sep 2025) to 165.77 Cr., marking an increase of 16.55 Cr..
- For Operating Profit, as of Dec 2025, the value is 3.71 Cr.. The value appears strong and on an upward trend. It has increased from 2.67 Cr. (Sep 2025) to 3.71 Cr., marking an increase of 1.04 Cr..
- For OPM %, as of Dec 2025, the value is 2.19%. The value appears strong and on an upward trend. It has increased from 1.76% (Sep 2025) to 2.19%, marking an increase of 0.43%.
- For Other Income, as of Dec 2025, the value is 2.48 Cr.. The value appears strong and on an upward trend. It has increased from 1.27 Cr. (Sep 2025) to 2.48 Cr., marking an increase of 1.21 Cr..
- For Interest, as of Dec 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Sep 2025) to 0.01 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Dec 2025, the value is 0.03 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.03 Cr..
- For Profit before tax, as of Dec 2025, the value is 6.15 Cr.. The value appears strong and on an upward trend. It has increased from 3.88 Cr. (Sep 2025) to 6.15 Cr., marking an increase of 2.27 Cr..
- For Tax %, as of Dec 2025, the value is 26.50%. The value appears to be increasing, which may not be favorable. It has increased from 25.77% (Sep 2025) to 26.50%, marking an increase of 0.73%.
- For Net Profit, as of Dec 2025, the value is 4.52 Cr.. The value appears strong and on an upward trend. It has increased from 2.88 Cr. (Sep 2025) to 4.52 Cr., marking an increase of 1.64 Cr..
- For EPS in Rs, as of Dec 2025, the value is 2.46. The value appears strong and on an upward trend. It has increased from 1.57 (Sep 2025) to 2.46, marking an increase of 0.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 442 | 335 | 293 | 375 | 483 | 372 | 404 | 865 | 1,013 | 597 | 625 | 622 |
| Expenses | 282 | 424 | 326 | 283 | 361 | 469 | 366 | 389 | 821 | 966 | 572 | 600 | 604 |
| Operating Profit | 10 | 18 | 9 | 9 | 14 | 14 | 6 | 15 | 44 | 47 | 25 | 26 | 18 |
| OPM % | 4% | 4% | 3% | 3% | 4% | 3% | 2% | 4% | 5% | 5% | 4% | 4% | 3% |
| Other Income | 1 | 1 | 3 | 4 | 4 | 1 | 4 | 0 | 2 | 2 | 4 | 5 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 11 | 19 | 12 | 13 | 18 | 14 | 10 | 15 | 47 | 48 | 30 | 30 | 27 |
| Tax % | 34% | 34% | 35% | 35% | 36% | 37% | 25% | 26% | 25% | 25% | 26% | 27% | |
| Net Profit | 7 | 12 | 8 | 9 | 12 | 9 | 7 | 11 | 35 | 36 | 22 | 22 | 20 |
| EPS in Rs | 4.08 | 6.73 | 4.36 | 4.76 | 6.36 | 4.83 | 4.07 | 6.19 | 19.01 | 19.44 | 11.91 | 12.18 | 10.69 |
| Dividend Payout % | 24% | 22% | 34% | 38% | 38% | 50% | 59% | 60% | 52% | 51% | 57% | 57% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 71.43% | -33.33% | 12.50% | 33.33% | -25.00% | -22.22% | 57.14% | 218.18% | 2.86% | -38.89% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -104.76% | 45.83% | 20.83% | -58.33% | 2.78% | 79.37% | 161.04% | -215.32% | -41.75% | 38.89% |
Vinyl Chemicals (I) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | -10% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | -17% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 25% |
| 3 Years: | -18% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 24 | 33 | 41 | 46 | 54 | 57 | 59 | 66 | 94 | 111 | 115 | 125 | 119 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Other Liabilities | 80 | 69 | 80 | 56 | 115 | 84 | 94 | 200 | 65 | 62 | 188 | 135 | 86 |
| Total Liabilities | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 | 207 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 9 | 45 | 39 | 34 | 2 | 47 | 55 | 78 | 40 | 57 | 68 | 0 |
| Other Assets | 100 | 95 | 78 | 66 | 137 | 141 | 108 | 214 | 84 | 135 | 247 | 193 | 206 |
| Total Assets | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 | 207 |
Below is a detailed analysis of the balance sheet data for Vinyl Chemicals (I) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Reserves, as of Sep 2025, the value is 119.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2025) to 119.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 86.00 Cr.. The value appears to be improving (decreasing). It has decreased from 135.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 49.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 207.00 Cr.. The value appears to be improving (decreasing). It has decreased from 262.00 Cr. (Mar 2025) to 207.00 Cr., marking a decrease of 55.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 68.00 Cr..
- For Other Assets, as of Sep 2025, the value is 206.00 Cr.. The value appears strong and on an upward trend. It has increased from 193.00 Cr. (Mar 2025) to 206.00 Cr., marking an increase of 13.00 Cr..
- For Total Assets, as of Sep 2025, the value is 207.00 Cr.. The value appears to be declining and may need further review. It has decreased from 262.00 Cr. (Mar 2025) to 207.00 Cr., marking a decrease of 55.00 Cr..
Notably, the Reserves (119.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 10.00 | 18.00 | 9.00 | 9.00 | 14.00 | 14.00 | 6.00 | 15.00 | 43.00 | 47.00 | 25.00 | 26.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 40 | 54 | 57 | 75 | 48 | 45 | 100 | 5 | 11 | 65 | 61 |
| Inventory Days | 48 | 33 | 29 | 23 | 57 | 53 | 50 | 70 | 24 | 33 | 78 | 39 |
| Days Payable | 99 | 53 | 88 | 69 | 116 | 63 | 95 | 188 | 26 | 22 | 118 | 78 |
| Cash Conversion Cycle | 15 | 20 | -5 | 11 | 17 | 39 | -1 | -17 | 3 | 22 | 25 | 23 |
| Working Capital Days | 16 | 19 | -4 | 10 | 19 | 36 | 2 | 2 | 7 | 26 | 32 | 27 |
| ROCE % | 45% | 57% | 24% | 21% | 30% | 24% | 14% | 23% | 55% | 44% | 22% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Diluted EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Cash EPS (Rs.) | 12.23 | 11.96 | 19.49 | 19.01 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Dividend / Share (Rs.) | 7.00 | 6.75 | 10.00 | 10.00 | 3.75 |
| Revenue From Operations / Share (Rs.) | 340.85 | 325.45 | 551.96 | 471.58 | 220.32 |
| PBDIT / Share (Rs.) | 16.65 | 16.25 | 26.70 | 25.54 | 8.34 |
| PBIT / Share (Rs.) | 16.59 | 16.20 | 26.64 | 25.54 | 8.34 |
| PBT / Share (Rs.) | 16.57 | 16.17 | 25.91 | 25.45 | 8.31 |
| Net Profit / Share (Rs.) | 12.17 | 11.91 | 19.43 | 19.01 | 6.19 |
| PBDIT Margin (%) | 4.88 | 4.99 | 4.83 | 5.41 | 3.78 |
| PBIT Margin (%) | 4.86 | 4.97 | 4.82 | 5.41 | 3.78 |
| PBT Margin (%) | 4.86 | 4.96 | 4.69 | 5.39 | 3.77 |
| Net Profit Margin (%) | 3.57 | 3.65 | 3.52 | 4.03 | 2.80 |
| Return on Networth / Equity (%) | 17.63 | 18.70 | 31.45 | 36.30 | 16.67 |
| Return on Capital Employeed (%) | 23.89 | 25.29 | 42.84 | 48.43 | 22.12 |
| Return On Assets (%) | 8.51 | 7.15 | 20.29 | 21.56 | 4.22 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 2.20 | 2.48 | 6.00 | 4.02 | 1.90 |
| Current Ratio (X) | 1.93 | 1.62 | 2.83 | 2.47 | 1.34 |
| Quick Ratio (X) | 1.46 | 0.97 | 1.46 | 1.66 | 0.97 |
| Inventory Turnover Ratio (X) | 6.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 55.42 | 83.94 | 51.44 | 19.72 | 38.76 |
| Dividend Payout Ratio (CP) (%) | 55.17 | 83.55 | 51.29 | 19.72 | 38.74 |
| Earning Retention Ratio (%) | 44.58 | 16.06 | 48.56 | 80.28 | 61.24 |
| Cash Earning Retention Ratio (%) | 44.83 | 16.45 | 48.71 | 80.28 | 61.26 |
| Interest Coverage Ratio (X) | 763.53 | 611.00 | 36.23 | 283.98 | 329.54 |
| Interest Coverage Ratio (Post Tax) (X) | 559.34 | 448.62 | 27.37 | 212.29 | 245.55 |
| Enterprise Value (Cr.) | 507.69 | 574.53 | 612.80 | 480.31 | 201.52 |
| EV / Net Operating Revenue (X) | 0.81 | 0.96 | 0.60 | 0.55 | 0.49 |
| EV / EBITDA (X) | 16.62 | 19.27 | 12.51 | 10.25 | 13.17 |
| MarketCap / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| Retention Ratios (%) | 44.57 | 16.05 | 48.55 | 80.27 | 61.23 |
| Price / BV (X) | 4.10 | 4.97 | 5.42 | 5.01 | 3.13 |
| Price / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.07 | 0.05 |
After reviewing the key financial ratios for Vinyl Chemicals (I) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 11.96 (Mar 24) to 12.23, marking an increase of 0.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 6.75 (Mar 24) to 7.00, marking an increase of 0.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 340.85. It has increased from 325.45 (Mar 24) to 340.85, marking an increase of 15.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 16.25 (Mar 24) to 16.65, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.59. This value is within the healthy range. It has increased from 16.20 (Mar 24) to 16.59, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.57. This value is within the healthy range. It has increased from 16.17 (Mar 24) to 16.57, marking an increase of 0.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has decreased from 4.99 (Mar 24) to 4.88, marking a decrease of 0.11.
- For PBIT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.97 (Mar 24) to 4.86, marking a decrease of 0.11.
- For PBT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.96 (Mar 24) to 4.86, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 5. It has decreased from 3.65 (Mar 24) to 3.57, marking a decrease of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.63. This value is within the healthy range. It has decreased from 18.70 (Mar 24) to 17.63, marking a decrease of 1.07.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.89. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 23.89, marking a decrease of 1.40.
- For Return On Assets (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 8.51, marking an increase of 1.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.20. It has decreased from 2.48 (Mar 24) to 2.20, marking a decrease of 0.28.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 1.93, marking an increase of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.46, marking an increase of 0.49.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.83, marking an increase of 6.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.42. This value exceeds the healthy maximum of 50. It has decreased from 83.94 (Mar 24) to 55.42, marking a decrease of 28.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 55.17. This value exceeds the healthy maximum of 50. It has decreased from 83.55 (Mar 24) to 55.17, marking a decrease of 28.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.58. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 44.58, marking an increase of 28.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 16.45 (Mar 24) to 44.83, marking an increase of 28.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 763.53. This value is within the healthy range. It has increased from 611.00 (Mar 24) to 763.53, marking an increase of 152.53.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 559.34. This value is within the healthy range. It has increased from 448.62 (Mar 24) to 559.34, marking an increase of 110.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 507.69. It has decreased from 574.53 (Mar 24) to 507.69, marking a decrease of 66.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.81, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 16.62. This value exceeds the healthy maximum of 15. It has decreased from 19.27 (Mar 24) to 16.62, marking a decrease of 2.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 44.57. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 44.57, marking an increase of 28.52.
- For Price / BV (X), as of Mar 25, the value is 4.10. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 4.10, marking a decrease of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinyl Chemicals (I) Ltd:
- Net Profit Margin: 3.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.89% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.63% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 559.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.6 (Industry average Stock P/E: 313.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Regent Chambers, 7th Floor, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M B Parekh | Chairman & Managing Director |
| Mr. N K Parekh | Director |
| Mr. A B Parekh | Director |
| Mr. P D Shah | Director |
| Mr. L Viswanathan | Director |
| Mrs. Shailashri Bhaskar | Director |
FAQ
What is the intrinsic value of Vinyl Chemicals (I) Ltd?
Vinyl Chemicals (I) Ltd's intrinsic value (as of 06 February 2026) is ₹156.42 which is 26.91% lower the current market price of ₹214.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹393 Cr. market cap, FY2025-2026 high/low of ₹357/207, reserves of ₹119 Cr, and liabilities of ₹207 Cr.
What is the Market Cap of Vinyl Chemicals (I) Ltd?
The Market Cap of Vinyl Chemicals (I) Ltd is 393 Cr..
What is the current Stock Price of Vinyl Chemicals (I) Ltd as on 06 February 2026?
The current stock price of Vinyl Chemicals (I) Ltd as on 06 February 2026 is ₹214.
What is the High / Low of Vinyl Chemicals (I) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vinyl Chemicals (I) Ltd stocks is ₹357/207.
What is the Stock P/E of Vinyl Chemicals (I) Ltd?
The Stock P/E of Vinyl Chemicals (I) Ltd is 20.6.
What is the Book Value of Vinyl Chemicals (I) Ltd?
The Book Value of Vinyl Chemicals (I) Ltd is 66.1.
What is the Dividend Yield of Vinyl Chemicals (I) Ltd?
The Dividend Yield of Vinyl Chemicals (I) Ltd is 3.28 %.
What is the ROCE of Vinyl Chemicals (I) Ltd?
The ROCE of Vinyl Chemicals (I) Ltd is 21.1 %.
What is the ROE of Vinyl Chemicals (I) Ltd?
The ROE of Vinyl Chemicals (I) Ltd is 15.6 %.
What is the Face Value of Vinyl Chemicals (I) Ltd?
The Face Value of Vinyl Chemicals (I) Ltd is 1.00.